Sue Gail Eckhardt Exelixis, Inc. (EXEL) insider trading activity

Sue Gail Eckhardt is Director of EXELIXIS, INC.. Currently has a direct ownership of 40,218 shares of EXEL, which is worth approximately $1.73 Million. The most recent transaction as insider was on May 29, 2025, when has been sold 9,812 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.2K

32.27% 3M change

17.38% 12M change

Total Value Held $1.73 Million

Sue Gail Eckhardt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2025	BUY Grant, award, or other acquisition	-	9,812 Added 19.61%	40,218 Common Stock
Feb 14 2025	SELL Open market or private sale	$405,227 $35.03 p/Share	11,568 Reduced 27.56%	30,406 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	$179,226 $23.24 p/Share	7,712 Added 15.52%	41,974 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	18,838 Added 35.48%	34,262 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	15,424 Added 50.0%	15,424 Common Stock

Also insider at

SYRS

Syros Pharmaceuticals, Inc. Healthcare

SGE